Access the full text.
Sign up today, get DeepDyve free for 14 days.
Q. Zeng, Zhiqin Li, Hong-xia Liang, Guang-Hua Xu, Chun-Xia Li, Da-wei Zhang, Wei Li, Chang-Yu Sun, Fu-sheng Wang, Zu-Jiang Yu (2016)
Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?Journal of hepatology, 65 5
M. Persico, Andrea Aglitti, A. Aghemo, M. Rendina, A. Lleo, A. Ciancio, V. Marco, P. Lampertico, M. Brunetto, M. Zuin, P. Andreone, E. Villa, G. Troshina, V. Calvaruso, E. Degasperi, B. Coco, Andrea Giorgini, F. Conti, A. Leo, L. Marzi, V. Boccaccio, S. Bollani, P. Maisonneuve, S. Bruno (2018)
High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 47
Toshie Mashiba, K. Joko, M. Kurosaki, H. Ochi, Y. Osaki, Y. Kojima, R. Nakata, T. Goto, Akahane Takehiro, H. Kimura, A. Mitsuda, C. Kawanami, Y. Uchida, C. Ogawa, A. Kusakabe, R. Narita, Y. Ide, T. Abe, K. Tsuji, Tadashi Kitamura, K. Okada, T. Sohda, Masaya Shigeno, Takashi Satou, N. Izumi (2018)
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study GroupPLoS ONE, 13
K. Ikeda, Y. Kawamura, M. Kobayashi, Yoko Kominami, Shunichiro Fujiyama, H. Sezaki, T. Hosaka, N. Akuta, S. Saitoh, F. Suzuki, Yoshiyuki Suzuki, Y. Arase, H. Kumada (2017)
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular CarcinomaDigestive Diseases and Sciences, 62
O. Falade-Nwulia, C. Suarez‐Cuervo, D. Nelson, M. Fried, J. Segal, M. Sulkowski (2017)
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.Annals of internal medicine, 166 9
H. Torres, J. Vauthey, M. Economides, P. Mahale, A. Kaseb (2016)
Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment.Journal of hepatology, 65 4
M. Reig, G. Cabibbo (2021)
Antiviral therapy in the palliative setting of HCC (BCLC B and C).Journal of hepatology
Mizuki Kinoshita, T. Minami, R. Tateishi, Taijiro Wake, Ryo Nakagomi, N. Fujiwara, Masaya Sato, Koji Uchino, K. Enooku, Hayato Nakagawa, Yoshinari Asaoka, S. Shiina, K. Koike (2019)
Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy.Journal of hepatology, 70 1
T Minami, R Tateishi, R Nakagomi (2016)
The impact of direct‐acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C‐related hepatocellular carcinoma, 65
F. Conti, F. Buonfiglioli, A. Scuteri, C. Crespi, L. Bolondi, P. Caraceni, F. Foschi, M. Lenzi, G. Mazzella, G. Verucchi, P. Andreone, S. Brillanti (2016)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals.Journal of hepatology, 65 4
C. Zavaglia, S. Okolicsanyi, L. Cesarini, C. Mazzarelli, V. Pontecorvi, A. Ciaccio, M. Strazzabosco, L. Belli (2017)
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?Journal of hepatology, 66 1
S. Pol (2016)
Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.Journal of hepatology, 65 4
(2019)
Cure with interferonfree directacting antiviral is associated with increased survival in patients with HCV related HCC from both East and West. Hepatology
S. Manthravadi, Swathi Paleti, P. Pandya (2017)
Impact of sustained viral response postcurative therapy of hepatitis C‐related hepatocellular carcinoma: a systematic review and meta‐analysisInternational Journal of Cancer, 140
M. Reig, Z. Mariño, C. Perelló, M. Iñarrairaegui, Andrea Ribeiro, S. Lens, A. Díaz, R. Vilana, A. Darnell, M. Varela, B. Sangro, J. Calleja, X. Forns, J. Bruix (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.Journal of hepatology, 65 4
(2017)
Directacting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis
G. Cabibbo, C. Celsa, V. Calvaruso, S. Petta, I. Cacciola, M. Cannavò, S. Madonia, M. Rossi, B. Magro, F. Rini, M. Distefano, L. Larocca, T. Prestileo, G. Malizia, G. Bertino, F. Benanti, A. Licata, I. Scalisi, G. Mazzola, M. Rosolini, G. Alaimo, A. Averna, F. Cartabellotta, N. Alessi, S. Guastella, M. Russello, G. Scifo, G. Squadrito, G. Raimondo, A. Craxì, V. Marco, C. Cammà (2019)
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsDigestive and Liver Disease
C. Cammà, G. Cabibbo, S. Petta, A. Craxì, Petta, A. Masotto, M. Renzulli, A. Olivani, P. Roselli, A. Cappelli, A. Ialungo, Tommaso Tovoli, E. Rinninella, V. Salvatore, E. Rastrelli, A. Affronti, G. Rapaccini, V. Vanin, V. Boccaccio, C. Mosconi, A. Moscatelli, A. Gazzola, Fabio Marra, A. Gasbarrini, C. Pozzan, Lucia Napoli, Attardo, Nicoletta Dematthaeis, A. Inghilesi, M. Marco, V. Mismas, F. Ciccarese, R. Golfieri, M. Guarino, F. Murer, A. Lanzi, Barbara, A. Gramenzi, F. Marchetti, A. Costantino, Giulia Negrini, G. Pellegatta, M. Valerio, Elga Neri, E. Vavassori, E. Biasini, S. Aburas, M. Zamparelli, S. Dell'isola, A. Dall'aglio, A. Mega, A. Ortolani, F. Rini, Marta Mascari, Paolo Delpoggio, M. Affronti, Napoli, M. Zoli, V. Feletti, Maurizio Pompili, G. Svegliati-Baroni, N. Bucci, F. Foschi, D. Magalotti, S. Olmi, F. Benevento, C. Balsamo, S. Tamberi, Piero Coccoli, A. Granito, A. Cucchetti, Virdone, M. Domenicali, M. Biselli, L. Benvegnu', F. Borzio, F. Morisco, A. Colecchia, G. Nardone, P. Caraceni, F. Piscaglia, Cammà, M. Felder, F. Farinati, M. Chiaramonte, F. Trevisani, G. Missale, E. Caturelli, A. Picciotto, R. Sacco, E. Giannini, M. Persico, S. Bruno, V. Savarino, Carla Serra, G. Stefanini, F. Cappa, M. Barbara, S. Attardo (2017)
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferonAlimentary Pharmacology & Therapeutics, 45
G. Ioannou, P. Green, K. Berry (2017)
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma.Journal of hepatology
P. Kolly, O. Waidmann, J. Vermehren, Christophe Moreno, Isabelle Vögeli, T. Berg, D. Semela, S. Zeuzem, J. Dufour (2017)
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study.Journal of hepatology, 67 4
V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, F. Montalto, M. Ammatuna, A. Morabito, L. Gennari (1996)
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.The New England journal of medicine, 334 11
A. Singal, N. Rich, N. Mehta, A. Branch, A. Pillai, M. Hoteit, M. Volk, M. Odewole, S. Scaglione, J. Guy, A. Said, J. Feld, Binu John, C. Frenette, P. Mantry, A. Rangnekar, Omobonike Oloruntoba, M. Leise, Janice Jou, K. Bhamidimarri, L. Kulik, G. Ioannou, A. Huang, T. Tran, H. Samant, R. Dhanasekaran, A. Duarte-Rojo, R. Salgia, S. Eswaran, P. Jalal, Avegail Flores, S. Satapathy, S. Kagan, P. Gopal, R. Wong, N. Parikh, C. Murphy (2019)
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular CarcinomaGastroenterology
G. Cabibbo, S. Petta, V. Calvaruso, I. Cacciola, M. Cannavò, S. Madonia, M. Distefano, L. Larocca, T. Prestileo, F. Tiné, G. Bertino, L. Giannitrapani, F. Benanti, A. Licata, I. Scalisi, G. Mazzola, F. Cartabellotta, N. Alessi, M. Barbara, M. Russello, G. Scifo, G. Squadrito, G. Raimondo, A. Craxì, V. Marco, C. Cammà (2017)
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre studyAlimentary Pharmacology & Therapeutics, 46
H. Nagata, M. Nakagawa, Y. Asahina, Ayako Sato, Yu Asano, Tomoyuki Tsunoda, M. Miyoshi, S. Kaneko, S. Otani, Fukiko Kawai‐Kitahata, M. Murakawa, S. Nitta, Yasuhiro Itsui, Seishin Azuma, S. Kakinuma, T. Nouchi, H. Sakai, M. Tomita, Mamoru Watanabe (2017)
Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C.Journal of hepatology, 67 5
L. Beste, P. Green, K. Berry, M. Kogut, S. Allison, G. Ioannou (2017)
Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma.Journal of hepatology, 67 1
C. Cammà, G. Cabibbo, A. Craxì (2016)
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing.Journal of hepatology, 65 4
Po‐Hong Liu, Chia-Yang Hsu, C. Hsia, Yun‐Hsuan Lee, C. Su, Yi‐Hsiang Huang, F. Lee, Han‐Chieh Lin, T. Huo (2016)
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems.Journal of hepatology, 64 3
L. Frazzoni, Usama Sikandar, F. Metelli, Sinan Sadalla, G. Mazzella, F. Bazzoli, L. Fuccio, F. Azzaroli (2021)
Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-AnalysisJournal of Clinical Medicine, 10
K. Imai, Koji Takai, T. Hanai, A. Suetsugu, M. Shiraki, M. Shimizu (2019)
Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatmentMolecular and Clinical Oncology, 12
K. Joko, T. Goto, Hiroshi Watanabe, Akari Mitsuda, Y. Uchida, C. Hasebe, S. Tsuruta, H. Kimura, T. Koike, Takuji Akamatsu, Toshie Mashiba, H. Ochi, Yoshiko Nakamura, K. Tsuchiya, M. Kurosaki, N. Izumi (2016)
Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study GroupHepatology Research, 46
H. Ochi, A. Hiraoka, M. Hirooka, Y. Koizumi, Michiko Amano, Nobuaki Azemoto, Takao Watanabe, O. Yoshida, Yoshio Tokumoto, Toshie Mashiba, T. Yokota, M. Abe, K. Michitaka, Y. Hiasa, K. Joko (2020)
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteriaJournal of Gastroenterology, 56
Improvements in the hepatocellular carcinoma (HCC) recurrence rate and survival have been frequently reported following virus eradication after hepatitis C virus (HCV)‐related HCC cure. However, the efficacy of direct‐acting antiviral (DAA) therapy in patients who included those with advanced HCC and decreased hepatic functional reserve is unknown. A comparative examination was retrospectively conducted of 141 patients with hepatitis C who started DAA therapy within 1 year after undergoing curative HCC treatment and showed a sustained viral response (SVR) and 327 patients who underwent curative treatment for HCV‐related HCC and did not subsequently receive antiviral therapy. Whether DAA therapy was given was identified as an independent factor related to both HCC recurrence and survival. Both the recurrence and survival rates improved significantly with DAA therapy in Child‐Pugh (CP)‐A, whereas no difference in the recurrence rate was seen with DAA therapy in CP‐B. However, the survival rate was significantly higher in the DAA group in this class. Similarly, dividing the patients by the Milan criteria showed significant improvements in the recurrence rate and survival with DAA therapy in patients within the Milan criteria. Patients with HCC beyond the Milan criteria showed no difference in recurrence rates, but the DAA group tended to have higher survival rates. Thus, DAA after curative therapy for HCC can be expected to improve survival in patients with advanced HCC or decreased hepatic functional reserve. HCV should be aggressively eradicated in all patients eligible for curative treatment of HCC.
Journal of Viral Hepatitis – Wiley
Published: Jul 1, 2022
Keywords: direct‐acting antiviral; hepatic functional reserve; hepatitis C virus; hepatocellular carcinoma; sustained viral response
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.